Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.